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THE KIDNEYS AND LIVER EXCRETE a structurally diverse array of compounds of physiological, pharmacological, and/or toxicological importance that share in common a net positive charge at physiological pH. Excretion of these "organic cations" (OCs) involves the concerted activity of transport processes at the basolateral (sinusoidal) and apical (canalicular) poles of renal proximal tubule (RPT) cells and hepatocytes, respectively. The cellular physiology of renal and hepatic OC secretion has been reasonably well-understood for 25 years, based on studies with isolated single RPTs (e.g., Ref. 24) and isolated basolateral and apical membrane vesicles from the kidney (e.g., Ref. 28 ) and liver (15) ; reviewed in Ref. 22 . The first step in secretion (uptake from the blood across the basolateral membrane of RPT, or the sinusoidal membrane of hepatocytes) is dominated by electrogenic OC-facilitated diffusion. The molecular identity of the basolateral component of renal OC transport is comparatively clear: in 1994, Gründemann et al. (2) cloned OCT1 from rat kidney, the initial member of what is now referred to as the SLC22A family of solute carriers. OCT1 (SLC22A1) displays all the hallmarks of OC transport determined initially in studies with isolated basolateral membrane vesicles and intact renal tubules, i.e., transport is electrogenic, independent of extracellular Na ϩ , has a selectivity for substrates that parallels closely that observed in relevant animal models, and is expressed in the basolateral (but not apical) membrane of RPT cells. Subsequent work identified at least 17 additional members of the SLC22A family, including OCT2 and OCT3 (SLC22A2 and SLC22A3, respectively) (9) . In the human there is strong agreement that OCT1 dominates sinusoidal OC transport in the liver, whereas OCT2 dominates OC transport in the kidney (10) . To summarize, the molecular basis of basolateral entry of type I OCs into hepatocytes and RPT cells (i.e., OCT1 and OCT2, respectively) is comparatively well-understood.
Until recently, there has been no such consensus concerning the molecular basis of the second step in renal and hepatic OC secretion (i.e., apical exit into the tubule filtrate/bile). Although several proteins have been proffered as possible candidates, including OCTN1 (29) and OCTN2 (16) , neither displays the "physiological fingerprint" of apical OC exit: 1) high levels of expression in kidney and liver, 2) subcellular localization at the apical pole of RPT cells and hepatocytes, 3) a mode of activity that supports secondary active exchange of H ϩ for OC, and 4) a broad selectivity for "type I OCs" (13) . 1 In late 2005, Otsuka et al. (18) indentified the first mammalian members of the Multidrug And Toxin Extruder (MATE) family of transporters, a group that includes some 1,000ϩ prokaryotic, fungal, and plant transport proteins (17) . MATE1 (now designated SLC47A1) displays the physiological fingerprint introduced above: it is heavily expressed in both human kidney and liver, it is localized to the apical pole of OC-secreting cells, and it operates as an OC/H ϩ exchanger of broad selectivity (26) . Despite the growing consensus that MATE1 [and its kidneyspecific homolog, MATE2-K (12)] plays a critical role in mediating OC secretion in kidney and liver, comparatively little is known about MATE structure, including its secondary topology. The vast majority of proteins in the MATE family of transporters appear (by computer analysis) to have 12 transmembrane helices (TMHs) with intracellular NH 2 and COOH termini [the latter generally consisting of a very hydrophilic ϳ100 residue cytoplasmic "tail" (23) ]. By extension, mammalian MATE1 (and MATE2-K) has also been proposed to have 12 TMHs (17, 18) . However, hydropathy analysis of the mammalian MATEs typically predicts the presence of 13 TMHs (26, 30) , the difference being the presence at the COOH terminus of mammalian MATEs of a long hydrophobic sequence that fulfills the criteria associated with helical structure and which is generally predicted to end at the external face of the membrane. In fact, we showed that an epitope-tagged construct of rabbit MATE1 has an extracellular COOH terminus, consistent with the presence of the putative 13th TMH (30) . It is notable that the mouse expresses both "short" and "long" forms of MATE1 (8) , the latter having this putative 13th TMH, whereas the former has a sequence similar to that of consensus 12 TMH MATE proteins. Both mMATE1 variants support transport and coexist in mice, indicating that the long hydrophobic sequence is not necessary for function and, rather than playing a structural role in the membrane, may instead interact with other proteins to form supramolecular complexes (8) .
In the present study, we examined in more detail the topology of the rabbit ortholog of MATE1 with a particular emphasis on establishing the location of the NH 2 and COOH termini of the predominant "long" form of this protein. The results confirmed that the COOH terminus of MATE1 is, in fact, extracellular, whereas the NH 2 terminus is intracellular, consistent with a 13 TMH model of MATE1 topology.
EXPERIMENTAL PROCEDURES

Chemicals.
[ ; 85 Ci/ mmol) was purchased from by Amersham Biosciences. (ϩ)-Biotinyl-3-maleimidopropionamidyl-3,6-dioxaoctanediamine (maleimide-PEO 2-biotin; "Mal-biotin") and sulfosuccinimidyl 2-(biotinamido)-ethyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin; "NHS-biotin") were obtained from Pierce Biotechnology; N-biotinylaminoethyl methanethiosulfonate ("MTS-biotin") was purchased from Toronto Research Chemicals. Platinum High Fidelity DNA polymerase, Zeocin, hygromycin, Flp recombinase expression plasmid (pOG44), and the mammalian expression vector pcDNA5/FRT/V5-His TOPO were obtained from Invitrogen. Other chemicals were typically of the highest grade available and, unless otherwise indicated, were purchased from Sigma.
TOPO cloning of rbMATE1 and site-directed mutagenesis. The open reading frame for rbMATE1 (contained in pcDNA3.1) was amplified using Platinum High Fidelity DNA polymerase and se- ; nucleotide sequence GGT AAG CCT ATC CCT AAC CCT CTC CTC GGT CTC GAT TCT ACG CGT ACC GGT CAT CAT CAC CAT CAC CAT). Mutations of the epitope-tagged rbMATE1 sequence were introduced by sitedirected mutagenesis using the Quick Change system following the manufacturer's instructions (Stratagene, La Jolla, CA). An NH 2-terminal V5-tagged MATE1 construct (with no epitope tag at the COOH-terminal end) and truncation mutants of the rbMATE1 sequence (with a V5/Poly-His epitope tag at the COOH-terminal end) were prepared using standard PCR methods, and the resulting PCR products were gel purified and cloned into pcDNA5/FRT/V5-His TOPO. Plasmid DNA was purified using standard methods (Genesee Scientific, San Diego, CA), and sequences were confirmed with an Applied Biosystems 3730xl DNA analyzer at the University of Arizona sequencing facility.
Cell culture and stable expression of rbMATE1. Chinese hamster ovary (CHO) cells containing a single integrated Flp Recombination Target (FRT) site were acquired from Invitrogen (CHO Flp-In) and were used for stable expression of the rbMATE1 mutant constructs. Before transfection, CHO Flp-In cells were grown in Ham's F12 Kaighn's modification medium (Sigma) supplemented with 10% fetal calf serum and Zeocin (100 g/ml). Cultures were split every 3 days. Cells (2 ϫ 10 6 ) were transfected by electroporation (BTX ECM 630, San Diego, 260 V and time constant of ϳ25 ms) with 10 g of salmon sperm, 18 g of pOG44, and 2 g of pcDNA5/FRT/V5-His TOPO containing the mutant constructs of rbMATE1. Cells were seeded in a T-75 flask following transfection and maintained under selection pressure with hygromycin (100 g/ml). Cells were used for experiments ϳ21 days after electroporation. In some cases, transport was measured in transiently transfected cells. Briefly, cells were transfected with 10 g of DNA at 260 V (time constant of ϳ25 ms) and seeded into 12-well plates at 320,000 cells/well. Uptake was typically measured 48 h after transfection, which was sufficient for the cells to reach confluence. Measurement of transport. CHO cells were incubated at room temperature (ϳ25°C) in Waymouth buffer (135 mM NaCl, 13 mM HEPES-NaOH, pH 7.4; 28 mM D-glucose, 5 mM KCl, 1.2 mM MgCl 2, 2.5 mM CaCl2, and 0.8 mM MgSO4) to which labeled substrate and appropriate test agents were added. Uptake was stopped by rinsing the cells three times with 2 ml of ice-cold Waymouth buffer. The cells were then solubilized in 400 l of 0.5 N NaOH with 1% (vol/vol) SDS, and the extract was subsequently neutralized with 200 l of 1 N HCl. Accumulated radioactivity was determined by liquid scintillation spectrometry. Rates of uptake are expressed as moles per centimeters squared of nominal cell surface of the confluent monolayer.
Immunocytochemistry. CHO cells were electroporated with plasmid DNA containing either an NH 2-terminal or COOH-terminal V5 epitope-tagged transporter and seeded onto coverslips. Immunocytochemistry was generally performed on a confluent monolayer 24 h after plating. Cells were fixed in ice-cold 100% methanol for 20 min ("permeabilized cells"), washed with PBS (137 mM NaCl, 2.7 mM KCl, 8.0 mM Na2HPO4, and 1.5 mM KH2PO4, pH 7; all washes were done in triplicate), and then incubated for 1 h with anti-V5 antibody (Invitrogen) diluted 1:500 in PBS. For "nonpermeabilized cells," cells were incubated with antibody for 1 h at room temperature first, fixed in ice-cold 100% methanol for 20 min, and then washed in PBS. The permeabilized and nonpermeabilized cells were then incubated for 1 h in the dark with fluorescein isothiocyanate-conjugated goat anti-mouse antibody (Molecular Probes) diluted 1:1,000 in PBS. To visualize the nuclei, cells were treated with propidium iodide (5 g/ml) for 10 min. Cells were washed again and the coverslips were mounted onto microscope slides using Dako fluorescence mounting media (Dako, Carpinteria, CA). A confocal microscope (Nikon PCM 2000 scan head fitted to a Nikon E800 microscope) was used for detection of immunoreactivity in CHO cells.
Cell surface biotinylation of MATE1. The method described here is a minor modification of that described by Pelis et al. (19) . All solutions were kept ice-cold throughout the procedure, and long incubations were conducted on ice with gentle shaking. Cells plated to confluence in a 12-well plate were initially washed three times with 2 ml of PBS solution containing calcium and magnesium (PBS/CM; containing in mM; 137 NaCl, 2.7 KCl, 8 Na2HPO4, 1.5 KH2PO4, 0.1 CaCl 2, and 1 MgCl2, pH 7.0 with HCl). Cells were then exposed for 30 min to either maleimide-PEO 2-biotin (0.5 mg/ml; Pierce Biotechnology) or Sulfo-NHS-SS-biotin (0.5 mg/ml; Pierce Biotechnology), diluted in PBS/CM. In some cases, plasma membranes were permeabilized before exposure to the biotinylation reagent by treating cells for 1 min with 0.02% saponin (in PBS/CM). After biotinylation, the cells were rinsed three times briefly with 3 ml of PBS/CM (this rinse contained 100 mM glycine in the experiments using Sulfo-NHSbiotin). The cells were lysed on ice for 1 h with gentle shaking in 1 ml of lysis buffer (150 mM NaCl, 10 mM Tris ⅐ HCl, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS, pH 7.4) containing protease inhibitors [in M: 200 4-(2-aminoethyl)-bezenesulfonyl-fluoride, 0.16 aprotinin, 4 leupeptin, 8 bestatin, 3 pepstatin A, 2.8 E-64; Sigma], after which 50 l of streptavidin-agarose beads (Pierce Biotechnology) were added to the lysates and incubated overnight at 4°C with constant mixing. After extensive washing with the above lysis buffer, 50 l of Laemmli sample buffer were added, and the proteins were eluted from the beads at 100°C for 5 min. Proteins were separated on 8% SDS-PAGE gels, transferred to PVDF membranes, and immunoreactivity corresponding to the V5-tagged MATE1 was visualized as previously described (19) .
Statistics. All data are expressed as means Ϯ SE, with calculations of standard errors based on the number of separate experiments conducted on cells at a different passage number. Statistical comparisons were performed using an unpaired t-test (ProStat 3.81; Poly Software Intl., Pearl River, NY).
RESULTS AND DISCUSSION
Hydropathy analysis of MATE family proteins. The prototypic member of the MATE family of transport proteins is the prokaryotic OC/Na exchanger, NorM (14) . By several different hydropathy algorithms, NorM appears to have 12 TMHs, although this has not been verified experimentally. There are currently over 1,000 different sequences for MATE family members (2.A.66.1; http://www.tcdb.org/tcdb/) and although the range of predicted TMHs runs from as few 2-5 to as many as 13, the vast majority (Ͼ80%) are predicted to have 12 TMHs. The mammalian MATE transporters, MATE1 (SLC47A1) and MATE2 (and its functional splice variant, MATE2-K; SLC47A2), however, typically display 13 TMHs by hydropathy analysis. 2 The consistent prediction of a 13th TMH reflects the presence in mammalian MATEs of a markedly hydrophobic COOH-terminal sequence of, on average, 25 amino acid residues (26, 30) . This is evident in the multiple alignment of several representative mammalian orthologs of MATE1 and MATE2-K, along with several prototypic prokaryotic MATE transporters (NorM, HmrM, PmpM, and AbeM; Supplemental Fig. S. 1 ; the online version of this article contains supplemental data). Nevertheless, most discussions of MATE structure have presumed, on the basis of the prototypic structure of prokaryotic MATEs, that the mammalian MATEs contain 12 TMHs with intracellular NH 2 and COOH termini (1, 4, 5, 8,  10, 17, 18 ). In fact, there have been no studies probing the topology of any MATE protein, prokaryotic or eukaryotic [other than our previous report showing that a COOH-terminal epitope tag on rbMATE1 is accessible to the external solution (30) ]. Here, we set out to establish the location of the NH 2 and COOH termini of MATE1 and resolve questions about the presence of a terminal TMH as a distinctive topological characteristic of the mammalian MATEs. 2 For example, the human and rabbit orthologs of MATE1 and MATE2-K are predicted to have 13 TMHs when analyzed using the hydropathy algorithms, HMMTOP, TMHMM2, ConPred II, Minnou, and Split 4.0. 
Assessment of NH 2 -and COOH-terminal location of fulllength MATE1 and selected MATE1 truncation mutants.
We used two distinct approaches, i.e., epitope tagging and cysteine scanning, to establish the location (intracellular vs. extracellular) of selected points along the sequence of rbMATE1. In the first of these complimentary approaches, we added a V5 epitope to the NH 2 terminus of full-length rbMATE1, or to the COOH terminus of either full-length rbMATE1 or truncated mutants of rbMATE1. We then determined whether a monoclonal antibody to V5 could access its epitope in cells with an intact plasma membrane (suggesting that the sequence is exposed to the external medium), or whether antibody interaction required permeabilization of the plasma membrane (suggesting that the sequence is exposed to the cytoplasmic face of the membrane). Figure 1 shows the results of these tests. Antibody interaction with the rbMATE1/V5-N term mutant only occurred after the plasma membrane had been permeabilized (by 20-min exposure to 100% methanol), consistent with the cytoplasmic location of the rbMATE1 NH 2 terminus. In contrast, V5 antibody interacted with the rbMATE1/V5-C term mutant in both nonpermeabilized and permeabilized cells, confirming our previous result (30) and supporting an extracellular location of the rbMATE1 COOH terminus. Together, these observations are consistent with an odd number of transmembrane-spanning domains from MATE1, e.g., 13 vs. 12.
The original sequence for mouse MATE1 (18) contained a frame shift mutation at position 510 that resulted in the early truncation of the protein, the net result being the elimination of 34 of the terminal 37 amino acid residues from what subsequently proved to be "full-length" mMATE1 (mMATE1b; Ref. 8) . The frame-shifted mMATE1 (MATE1a) proved to be fully functional, despite ending at a residue corresponding to position 540 in rbMATE1, a site immediately proximal to the hydrophobic sequence that comprises the putative 13th TMH (8) . When rbMATE1 was truncated at position 540 (and tagged at that point with the V5 epitope), interaction with antibody was restricted to permeabilized cells (Fig. 1F) , indicative of a cytoplasmic location of the truncated COOH terminus. In other words, elimination of the terminal hydrophobic sequence that distinguishes the mammalian MATEs from others members of this family resulted in a protein with intracellular NH 2 and COOH termini, consistent with an even number (e.g., 12) of TMHs. Truncation of rbMATE1 at positions 464 and 504, which lie at the "beginning" and "midpoint" of the long cytoplasmic loop between putative helices 12 and 13, resulted in protein constructs which successfully trafficked to, and were inserted in, the membrane, and, in both cases, had COOH termini which were accessible to antibody only after permeabilizing the membrane (Fig. 1, D and E) , consistent with their predicted cytoplasmic locations.
Function of rbMATE1 truncation mutants. With the demonstration that each of the rbMATE1 truncation mutants trafficked to the plasma membrane (Fig. 1) , we then determined the degree to which the changes in MATE1 structure associ- (Fig. 2) , the rates of transport were substantially lower than that of the full-length protein. The 540 trunc mutant corresponded in length to the functional mMATE1b variant described earlier (4, 8) and of the three truncation mutants studied it supported the highest level of MPP ϩ transport. Figure 3 compares the kinetics of MPP ϩ transport in CHO cells that expressed either the full-length sequence of rbMATE1, or the 540 trunc mutant. In both cases, MPP ϩ transport was adequately described by the Michaelis-Menten equation, as transformed by Malo and Berteloot (11) transport by the two constructs also did not differ significantly (3.6 Ϯ 0.8 vs. 2.5 Ϯ 0.5 pmol⅐cm Ϫ2 ⅐min Ϫ1 ), but this observation is misleading because of marked differences in the level of plasma membrane expression of the full-length vs. truncated MATE1 constructs. Figure 4A compares the rate of mediated transport of 15 nM [ 3 H]MPP ϩ into wild-type CHO cells and CHO cells that expressed either the full-length or 540 trunc constructs of MATE1 and shows that the cells that expressed the truncated protein supported 70% of the transport observed in the full-length-expressing cells. Figure 4B is a Western blot of transport protein expressed in the plasma membrane of these cells, as shown through interaction with three different impermeant biotinylation reagents, i.e., the lysine-reactive reagent, NHS-biotin, and two thiol-reactive reagents, Mal-biotin and MTS-biotin. Although all three compounds reacted with both the full-length and truncated MATE1 constructs, the level of expression of the truncated protein was ϳ9.7 times that of the full-length protein (based on densitometric analysis of the Western blot). Consequently, the rate of 540 trunc -mediated transport, when normalized to transport expressed at the plasma membrane, was only ϳ7% that of the full-length protein. In other words, whereas elimination of the terminal TMH of rbMATE1 did not significantly influence the binding of MPP to the transporter, it did appear to cause a ϳ14-fold decrease in turnover of the substrate-transporter complex.
In parallel experiments, we compared the inhibitory effect of TEA on MPP ϩ transport mediated by full-length rbMATE1 and the 540 trunc mutant (Fig. 3, C and D) . Again, although absolute rates of MPP ϩ transport differed by ϳ15-fold, the IC 50 for TEA's interaction with the two transporters did not differ significantly (P Ͼ 0.05; n ϭ 3), again suggesting that the terminal TMH of MATE1 has little influence on the affinity of the transporter for substrate and, instead, is limited to an influence of transporter turnover.
Preparation of effectively cysteine-less rbMATE1. Although the extracellular location of the COOH terminus of the V5-tagged rbMATE1 construct was quite evident, we had some concern that the addition of the very polar V5/poly-His epitope tag to what is otherwise a profoundly hydrophobic COOHterminal sequence could have influenced its final location. In other words, it was conceivable that, in the absence of this very polar sequence, the COOH terminus could reside in the cytoplasm, consistent with the common view that MATE family members, including the mammalian MATEs, have 12 (i.e., an even number of) transmembrane-spanning domains.
To test this possibility, we used the substituted cysteine accessibility method (SCAM) to probe the proposed MATE1 topology (Fig. 5A) . The wild-type sequence of MATE1 interacted with both NHS-biotin and Mal-biotin (Fig. 5B) , indicating the presence of accessible -NH 2 (lysine) and -SH (cysteine) moieties, respectively, within those elements of rbMATE1 that are exposed to the external medium. Consequently, application of SCAM required creation of a mutant MATE1 protein in which all accessible cysteine residues were replaced with residues that do not react with thiol-reactive reagents. Although we did replace the 14 native cysteine residues of rbMATE1 ( Fig. 5A ) with alanine residues, the resulting "⌬14Cys" mutant proved to be nonfunctional; it neither trafficked to the membrane nor supported measurable transport (data not shown). However, elimination of all the native cysteine residues except C129 resulted in a protein ("⌬13Cys") that trafficked to the membrane and retained transport function (Fig. 5, C and D) . Moreover, ⌬13Cys proved to be refractory to Mal-biotin, while retaining reactivity with NHS-biotin (Fig.  5B) . The ⌬13Cys mutant, representing the full-length of MATE1, was then used to determine the external accessibility of the sites probed in the truncation study. Introduction of a single-cysteine residue (single-cys) at the NH 2 -terminal end of ⌬13Cys (A3C) resulted in a protein that trafficked to the membrane and retained transport function (Fig. 6) , suggesting that the mutant protein was folded correctly. Consistent with its expression at the plasma membrane, the A3C/⌬13Cys mutant reacted with NHS-biotin, but did not react with Mal-biotin unless the membrane had been rendered permeable to the reagent (with saponin; Fig. 7) , confirming that the NH 2 terminus of MATE1 is intracellular. Similarly, the A464C, L504C, and L540C single-cys mutants also tracked to the membrane, supported transport, and reacted with NHS-biotin, but not with Mal-biotin (Fig. 7) . However, addition of a single-cys at the COOH terminus of rbMATE1 (C568Q) resulted in a protein that reacted with both the NHS-and MAL-biotin probes (without prior permeabilization of the membrane), indicating that the COOH-terminal end of MATE1 is exposed to the external solution (Fig. 8) .
The presence of an intracellular NH 2 terminus and an extracellular COOH terminus indicates that MATE1 contains an odd number of transmembrane-spanning domains. This appears to place the mammalian members of the MATE family of transporters at odds with the prokaryotic, fungal, and plant members of the MATE family (currently numbering over 1,000), which are generally viewed as having a core topology that includes 12 TMHs (17, 23) . Figure 9 shows an unrooted dendrogram displaying the predicted phylogenetic relationships between several pro- Fig. 8 . Extracellular accessibility of the single COOH-terminal cysteine residue in the Q568C mutant of ⌬13Cys construct of rbMATE1. A: reaction of rbMATE1 (WT), the ⌬13Cys mutant, and the Q568C single-cys mutant with NHS-biotin. All 3 proteins were expressed at the plasma membrane and contained lysine residues that were accessible to the extracellular reagent. The lower apparent molecular mass of the Q568C mutant reflected the absence of 9 amino acid residues associated with the poly-His element (and associated linker residues) that were present, along with V5, in the COOH-terminal epitope in the MATE1 and ⌬13Cys mutants; the Q568C mutant contained only an NH2-terminal V5 tag. B: reaction of these proteins with maleimide-biotin (Mal-bio). The WT protein was freely accessible to the impermeant thiolreactive reagent, whereas the ⌬13Cys mutant contained no thiol groups accessible to the reagent. The single COOH-terminal cysteine residue in the Q568C mutant was freely accessible to the extracellular, impermeant reagent. The WT and ⌬13Cys lanes contained 20 l of the reaction mixture; owing to the reduced level of expression of Q568C protein at the membrane (Fig. 6) , the Q568C lanes contained 50 l of reaction mixture. karyotic MATE members [including those shown to support OC/H ϩ exchange vs. the OC/Na ϩ exchange activity that appears to be a more common mode of MATE transporter function (17) ] and representative fungal, plant, and mammalian MATE transporters. The sequences of mammalian MATE proteins appear to have gained an additional hydrophobic COOH-terminal sequence that has modified their core topology to include 13, rather than 12, TMHs.
The functional impact of this additional (13th?) TMH is not clear. Not only does the core topology of MATE transporters appear to consist of 12 TMHs, the 13th TMH is not necessary for mammalian MATE function. The two expressed forms of mouse MATE1 (i.e., the truncated, 12 TMH, and full, 13 TMH forms) display similar functional properties (4, 8) , and the elimination of the last (13th) TMH of rbMATE1 does not appear to influence the affinity of rbMATE1 for (at least) selected substrates (Fig. 3) . If it does not play a direct role in transport activity, what does this highly conserved structural characteristic do? Kobara et al. (8) suggested that the hydrophobic terminal sequence of MATE1 could play a role in the formation of "supramolecular complexes." The fact that this terminal sequence lies within the membrane as a membranespanning helix (Figs. 2 and 7) , rather than within the cytoplasm (8), does not preclude a role for this region in mediating protein-protein interactions within the membrane. Indeed, increasing evidence supports the view that OC (7) and organic anion (6) transporters (from the SLC22A family of xenobiotic transporters), neither of which has long NH 2 -or COOHterminal cytoplasmic domains (20, 21, 31) , form multimeric complexes. The extent to which multimerization occurs in these transporters, or in the MATEs, and the influence it has on renal secretory processes, remains to be assessed. In addition, clarification of the complete secondary structure of MATE transporters will be required as part of any program to establish clear structure/function relationships for this key element in renal drug transport.
The observation that elimination of the 13th TMH appears to decrease the turnover number of the substrate/transporter complex invites another suggestion concerning "why" all mammalian MATEs appear to have 13 TMHs, rather than just the core structure of 12 TMHs found more routinely in nonmammalian members of the MATE transporter family. Is it possible that the addition of a COOH-terminal TMH, although having little apparent impact on the structure of the substrate binding region within the protein, increases the frequency with which the core structure of 12 TMHs undergoes the shifts in conformation that result in substrate translocation? If so, high rates of transport could be sustained with substantially less protein, a clear advantage when considering the limited area of membrane available for expression of the large array of distinct transport proteins that populate apical membranes of barrier epithelial cells.
